Edition:
India

PDL BioPharma Inc (PDLI.OQ)

PDLI.OQ on NASDAQ Stock Exchange Global Select Market

2.79USD
16 Jan 2018
Change (% chg)

-- (--)
Prev Close
$2.79
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
441,091
52-wk High
$3.55
52-wk Low
$1.96

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 62.75 0.136
Jun '17 143.84 0.386
Mar '17 45.44 0.044
FY 2016 Dec '16 66.49 -0.063
Sep '16 53.64 0.085
Jun '16 21.05 0.025
Mar '16 103.12 0.341
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 57.30 72.50 42.10 --
Quarter Ending Jun-18 2 59.60 75.60 43.60 --
Year Ending Dec-18 3 194.03 307.80 104.20 176.59
Earnings (per share)
Quarter Ending Mar-18 2 0.10 0.20 0.01 --
Quarter Ending Jun-18 2 0.12 0.21 0.03 --
Year Ending Dec-18 3 0.31 0.91 -0.07 0.16
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -58.62 -18.80 -7.57
EPS (TTM) % -80.96 -38.44 -6.64
Dividend % -83.33 -44.97 -30.12
Note: Units in Millions of US Dollars

Performance for PDL BioPharma Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 7.89 4.17 70 --
13 Week 43.70 36.70 88 --
26 Week 66.02 53.40 90 --
52 Week 5.23 -10.81 54 --
YTD 61.32 41.67 80 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 91.04%
# of Holders: 264
Total Shares Held: 140,506,434
3 Mo. Net Change: 157,836
# New Positions: 3
# Closed Positions: 2
# Increased Positions: 9
# Reduced Positions: 6
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.